发明名称 TRICYCLIC MODULATORS OF TNF SIGNALING
摘要 The invention provides tricyclic heterocyclic compounds, pharmaceutically acceptable salts, prodrugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variables are defined herein. The compounds of the invention may be useful for treating immunological and oncological conditions.
申请公布号 WO2016168641(A1) 申请公布日期 2016.10.20
申请号 WO2016US27814 申请日期 2016.04.15
申请人 ABBVIE INC. 发明人 BREINLINGER, Eric, C.;COX, Phil, B.;DAANEN, Jerome;DIETRICH, Justin;DJURIC, Stevan;DOMBROWSKI, Amanda, W.;FRANK, Kristine, E.;FRIEDMAN, Michael, M.;GOMTSYAN, Arthur;LI, Huan-Qui;LONGENECKER, Kenton;OSUMA, Augustine;ROWLEY, Ann, Marie;SCHMIDT, Robert;VASUDEVAN, Anil;WILSON, Noel
分类号 C07D471/04;A61K31/437;A61P37/00;C07D471/14;C07D487/04;C07D498/04;C07D498/14;C07D498/18;C07D498/20;C07D498/22;C07D519/00 主分类号 C07D471/04
代理机构 代理人
主权项
地址